Business Description
Forte Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US34962G1094
Share Class Description:
FBRX: Ordinary SharesDescription
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.9 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18.9 | |||||
3-Year EPS without NRI Growth Rate | 20.1 | |||||
3-Year FCF Growth Rate | 28.6 | |||||
3-Year Book Growth Rate | -40.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.75 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.4 | |||||
9-Day RSI | 55.52 | |||||
14-Day RSI | 53.27 | |||||
6-1 Month Momentum % | -21.01 | |||||
12-1 Month Momentum % | -44.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.45 | |||||
Quick Ratio | 9.45 | |||||
Cash Ratio | 9.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -99.06 | |||||
ROA % | -86.05 | |||||
ROIC % | -2628.12 | |||||
ROC (Joel Greenblatt) % | -38991.25 | |||||
ROCE % | -103.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.73 | |||||
Price-to-Tangible-Book | 0.73 | |||||
EV-to-EBIT | 0.3 | |||||
EV-to-EBITDA | 0.3 | |||||
EV-to-FCF | 0.33 | |||||
Price-to-Net-Current-Asset-Value | 0.75 | |||||
Price-to-Net-Cash | 0.78 | |||||
Earnings Yield (Greenblatt) % | 333.33 | |||||
FCF Yield % | -142.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FBRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Forte Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.88 | ||
Beta | 1.39 | ||
Volatility % | 93.71 | ||
14-Day RSI | 53.27 | ||
14-Day ATR ($) | 0.061701 | ||
20-Day SMA ($) | 0.52927 | ||
12-1 Month Momentum % | -44.1 | ||
52-Week Range ($) | 0.38 - 1.03 | ||
Shares Outstanding (Mil) | 36.44 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Forte Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Forte Biosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Forte Biosciences Inc Frequently Asked Questions
What is Forte Biosciences Inc(FBRX)'s stock price today?
The current price of FBRX is $0.58. The 52 week high of FBRX is $1.03 and 52 week low is $0.38.
When is next earnings date of Forte Biosciences Inc(FBRX)?
The next earnings date of Forte Biosciences Inc(FBRX) is 2024-08-14 Est..
Does Forte Biosciences Inc(FBRX) pay dividends? If so, how much?
Forte Biosciences Inc(FBRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |